Search by Drug Name or NDC

    NDC 55111-0329-01 Nateglinide 120 mg/1 Details

    Nateglinide 120 mg/1

    Nateglinide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is NATEGLINIDE.

    Product Information

    NDC 55111-0329
    Product ID 55111-329_1f405b49-b32b-876e-3ef0-ea4f8b9473c5
    Associated GPIs 27280040000330
    GCN Sequence Number 047292
    GCN Sequence Number Description nateglinide TABLET 120 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 34027
    HICL Sequence Number 021859
    HICL Sequence Number Description NATEGLINIDE
    Brand/Generic Generic
    Proprietary Name Nateglinide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Nateglinide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 120
    Active Ingredient Units mg/1
    Substance Name NATEGLINIDE
    Labeler Name Dr. Reddy's Laboratories Limited
    Pharmaceutical Class Glinide [EPC], Potassium Channel Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077461
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0329-01 (55111032901)

    NDC Package Code 55111-329-01
    Billing NDC 55111032901
    Package 100 TABLET in 1 BOTTLE (55111-329-01)
    Marketing Start Date 2009-09-09
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL f7b28951-76d2-cabd-64a1-b74aa225c6e9 Details

    Revised: 11/2021